Advanced Viral Research CP (ADVR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Advanced Viral Research CP (ADVR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: joe mazzeo who wrote (382)	6/17/1996 5:58:00 PM
From: stan louie	of 2281

If this goes to $5, I will be happy. I don't think this drug has the potential of more than $30, because no strong data as to the effectiveness of this agent. If anyone has medline data, please share with the rest of us. I got in because of the hype, not the pharmacological activity. Dr. H does not have a strong record, so I would be careful about saying this drug could go to $100. It isn't even on the fast track list. I would be cautious. Since I am in, I am staying.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next